Increasing HIV drug resistance in newly diagnosed infants
from Infectious Disease Advisor
According to data published in BMC Infectious Diseases, nonnucleoside reverse transcriptase inhibitor resistance has increased among newly diagnosed infants who live in a high HIV prevalence setting where maternal antiretroviral therapy coverage increased across years. Researchers conducted a sub-study of three nationally representative cross-sectional surveys in South Africa in 2010, 2011 to 2012 and 2012 to 2013 to address several questions surrounding mother to child transmission of HIV.
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063